3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
1
Hyperandrogenism
1
Interventions
fludarabine
17
Cyclophosphamide
16
Positron Emission Tomography Computed Tomography
4
Oncolytic Virotherapy
4
Metformin
4
68Ga-pentixafor
4
lenvatinib
3
Radiosurgery
3
Pemetrexed
3
Paclitaxel
3
Melphalan
3
Immunotherapy, Adoptive
3
Gemcitabine
3
Cholestanetriol 26-Monooxygenase
3
Carboplatin
3
68Ga-NOTA-RM26
3
toripalimab
2
sintilimab
2
pembrolizumab
2
gallium Ga 68 dotatate
2
gallium 68 PSMA-11
2
fludarabine phosphate
2
alpha-Synuclein
2
Progesterone
2
Nivolumab
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
Influenza Vaccines
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Unknown
×
Spironolactone
×
Clear all
NCT04075149
2023-10-27
CBS009
University of Virginia
Phase EARLY_PHASE1
Unknown
24 enrolled